Detalhe da pesquisa
1.
Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.
Ophthalmology
; 127(2): 186-195, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31474439
2.
Onset and Progression of Persistent Choroidal Hypertransmission Defects in Intermediate Age-Related Macular Degeneration: A Novel Clinical Trial Endpoint.
Am J Ophthalmol
; 254: 11-22, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36958537
3.
Ranibizumab for neovascular age-related macular degeneration.
N Engl J Med
; 355(14): 1419-31, 2006 Oct 05.
Artigo
Inglês
| MEDLINE | ID: mdl-17021318
4.
Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): year 2 results.
Am J Ophthalmol
; 145(5): 862-74, 2008 May.
Artigo
Inglês
| MEDLINE | ID: mdl-18321465
5.
Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study.
Arch Ophthalmol
; 124(11): 1532-42, 2006 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-17101999